bf/NASDAQ:HOOK_icon.jpeg

NASDAQ:HOOK

HOOKIPA Pharma Inc.

  • Stock

1.32

+38.95%

0.44

USD last updated 20/08 01:59:44

Last Close

0.88

08/08 19:48

Market Cap

531.03M

Beta: 0.82

Volume Today

1.26M

Avg: 433.92K

PE Ratio

−0.77

PFCF: −1.39

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-pos...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -10-8-6-4-22018-03-302019-05-202021-05-122023-05-112024-11-07

    Revenue (Estimate*)

    2M4M6M8M10M12M2018-03-302019-05-202021-05-122023-05-112024-11-07

    *Estimate based on analyst consensus